Drug Trial Radar · NCT05952869
A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)
Last checked: Nov 20, 2026Latest source record: Feb 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
303
Actual
Start
Aug 8, 2023
Primary completion
Apr 7, 2025
Study completion Apr 7, 2025
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Jul 19, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate the efficacy, safety, and tolerability of enlicitide decanoate in adult participants with heterozygous familial hypercholesterolemia. The primary hypothesis is that enlicitide decanoate is superior to placebo on mean percent change from baseline in low-density lipoprotein cholesterol (LDL-C) at Week 24.
Conditions
- Hypercholesterolemia
- Familial Hypercholesterolemia
Interventions
Enlicitide DecanoateDrug
Oral tablet
PlaceboDrug
Oral tablet (placebo).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline in Low-Density Lipoprotein Cholesterol (LDL-C) at Week 24Time frame: Baseline and Week 24
- Number of Participants With Adverse Events (AEs)Time frame: Up to 64 weeks (8 weeks postdose)
- Number of Participants Who Discontinued Study Drug Due to an AETime frame: Up to 56 weeks
Locations
59 sites in 17 countries. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC ( Site 0023)
Daphne, Alabama
Excel Medical Clinical Trials ( Site 0008)
Boca Raton, Florida
Advanced Pharma Research ( Site 0007)
Cutler Bay, Florida
Progressive Medical Research ( Site 0021)
Port Orange, Florida
Clinical Site Partners LLC, dba CSP Orlando ( Site 0028)
Winter Park, Florida
Synexus Clinical Research US - Evansville ( Site 0031)
Evansville, Indiana
Franciscan Physician Network - Indiana Heart Physicians ( Site 0040)
Indianapolis, Indiana
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0001)
Troy, Michigan
Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0026)
Lincoln, Nebraska
Jubilee Clinical Research ( Site 0030)
Las Vegas, Nevada
Wake Forest Baptist Health-Cardiovascular Medicine ( Site 0041)
Winston-Salem, North Carolina
Velocity Clinical Research, Salt Lake City ( Site 0004)
West Jordan, Utah
Health Research of Hampton Roads, Inc. ( Site 0020)
Newport News, Virginia
Royal Prince Alfred Hospital-6West CV Ambulatory Care ( Site 2808)
Camperdown, New South Wales, Australia
Victorian Heart Hospital-Monash Cardiovascular Research Centre (MCRC) ( Site 2803)
Clayton, Victoria, Australia
Incor - Instituto do Coracao ( Site 0703)
São Paulo, Brazil
Universidade Federal Do Ceara ( Site 0702)
Fortaleza, Ceará, Brazil
Instituto Dante Pazzanese de Cardiology-Fundação Adib Jatene ( Site 0701)
São Paulo, São Paulo, Brazil
Ecogene-21 ( Site 0510)
Chicoutimi, Quebec, Canada
Institut de Cardiologie de Montreal ( Site 0506)
Montreal, Quebec, Canada
Diex Recherche Trois-Rivieres ( Site 0513)
Trois-Rivières, Quebec, Canada
Clinical Research Chile SpA ( Site 0804)
Valdivia, Los Ríos Region, Chile
CDIEM ( Site 0814)
Providencia, Region M. de Santiago, Chile
Enroll SpA ( Site 0803)
Santiago, Region M. de Santiago, Chile
Pontificia Universidad Catolica de Chile-CICUC ( Site 0812)
Santiago, Region M. de Santiago, Chile
Fundación Centro de Investigación Clínica CIC ( Site 0906)
Medellín, Antioquia, Colombia
Ciensalud Ips S A S ( Site 0903)
Barranquilla, Atlántico, Colombia
Clinica de la Costa S.A.S. ( Site 0902)
Barranquilla, Atlántico, Colombia
Salud SURA Calle 100 ( Site 0918)
Bogotá, Cundinamarca, Colombia
Fakultní nemocnice Brno Bohunice-Interni kardiologicka klinika ( Site 3602)
Brno, Brno-mesto, Czechia
Institut Klinicke a Experimentalni Mediciny ( Site 3601)
Prague, Praha 4, Czechia
Fakultni Nemocnice u sv. Anny v Brne ( Site 3604)
Brno, South Moravian, Czechia
Meilahden tornisairaala - Meilahti Tower Hospital ( Site 1300)
Helsinki, Uusimaa, Finland
Queen Mary Hospital-Medical ( Site 3300)
Pok Fu Lam, Hong Kong
Prince of Wales Hospital ( Site 3304)
Shatin, Hong Kong
Semmelweis Egyetem-Városmajori Szív- és Érgyógyászati Klinika ( Site 1600)
Budapest, Hungary
Debreceni Egyetem Klinikai Kozpont-Belgyógyászati Klinika (Anyagcsere Tanszék) ( Site 1601)
Debrecen, Hungary
Szegedi Tudományegyetem Szent-Györgyi Albert Klinikai Központ-Belgyógyászati Klinika ( Site 1603)
Szeged, Csongrád megye, Hungary
Shaare Zedek Medical Center ( Site 1710)
Jerusalem, Israel
Hadassah Medical Center ( Site 1709)
Jerusalem, Israel
Showing 40 of 59 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.